Investor Presentaiton
RECONCILIATION OF OPERATING TO STATUTORY EBITDA & NPAT
AUD $m
1H FY23
1H FY22
Operating NPAT
7.8
12.3
Change ($)
(4.5)
Change (%)
(36.4%)
Non operating transactions net of tax
Transaction and integration benefits/(costs)
10.4
(0.7)
Share based expenses
(1.0)
(0.7)
Share of net profit of joint ventures
(0.2)
(0.1)
Amortisation of customer contracts
Statutory NPAT
AUD $m
Operating EBITDA
Non operating transactions
Transaction and integration costs
Share based expenses
(0.9)
(1.0)
16.1
10.2
5.9
58.2%
1H FY23
1H FY22
39.8
38.8
Change ($)
0.9
Change (%)
2.4%
Share of net profit of joint ventures
Statutory EBITDA
9.7
(0.7)
(1.0)
(0.5)
(0.2)
(0.1)
48.2
37.5
10.7
28.6%
•
•
1H FY23 transaction and integration costs consist of adjustments to contingent consideration provisions for
Imaging Queensland and the X-Ray Group resulting from the reassessment of estimated future earnout payments
($14.1m write back), offset by $2.0m of one-off system implementation costs and other one-off costs of $1.7m
relating to acquisitions and integration activities.
1H FY23 non-operating share-based expenses primarily relate to the loan funded share/option plan
for radiologists. In 1H FY23, the management LTI plan expense has been recorded as part of
operating labour expenses. The 1H FY22 LTI plan expense presented above has been reallocated to
ensure consistent presentation.
1H FY23 amortisation of customer contracts relates to the acquisition of Imaging
Queensland ($0.3m), Astra Radiology ($0.5m), Horizon Radiology ($0.3m) and the X-Ray
Group ($0.1m) on a pre-tax basis.
idxView entire presentation